San Fu Chemical Co., Ltd.
TWSE:4755.TW
121 (TWD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,990.961 | 5,618.6 | 4,779.885 | 3,818.716 | 3,936.381 | 4,049.356 | 3,979.248 | 3,816.849 | 3,507.392 | 3,483.929 | 3,221.961 | 3,710.849 | 3,902.282 | 3,129.9 |
| Cost of Revenue
| 4,048.458 | 4,116.036 | 3,584.78 | 2,957.612 | 3,249.525 | 3,289.001 | 3,187.562 | 3,137.567 | 3,061.789 | 3,156.607 | 2,844.839 | 3,181.684 | 3,455.408 | 2,747.053 |
| Gross Profit
| 942.503 | 1,502.564 | 1,195.105 | 861.104 | 686.856 | 760.355 | 791.686 | 679.282 | 445.603 | 327.322 | 377.122 | 529.165 | 446.874 | 382.847 |
| Gross Profit Ratio
| 0.189 | 0.267 | 0.25 | 0.225 | 0.174 | 0.188 | 0.199 | 0.178 | 0.127 | 0.094 | 0.117 | 0.143 | 0.115 | 0.122 |
| Reseach & Development Expenses
| 80.609 | 63.301 | 38.615 | 40.907 | 27.444 | 12.344 | 16.547 | 18.012 | 19.954 | 19.854 | 18.558 | 28.937 | 42.794 | 44.523 |
| General & Administrative Expenses
| 169.008 | 222.96 | 172.582 | 145.175 | 116.009 | 118.502 | 112.778 | 103.714 | 94.22 | 85.342 | 93.966 | 84.201 | 65.068 | 69.422 |
| Selling & Marketing Expenses
| 214.843 | 286.395 | 256.706 | 204.119 | 204.767 | 216.051 | 188.551 | 178.956 | 163.539 | 158.754 | 144.789 | 189.168 | 180.661 | 189.144 |
| SG&A
| 303.977 | 509.355 | 429.288 | 349.294 | 320.776 | 334.553 | 301.329 | 282.67 | 257.759 | 244.096 | 238.755 | 273.369 | 245.729 | 258.566 |
| Other Expenses
| 0 | 81.781 | 33.299 | 30.855 | 14.524 | 81.654 | -9.598 | 23.669 | 23.369 | 54.699 | 22.5 | 29.216 | 25.368 | 26.684 |
| Operating Expenses
| 464.46 | 572.656 | 467.903 | 390.201 | 348.22 | 346.897 | 317.876 | 300.682 | 277.713 | 263.95 | 257.313 | 302.306 | 288.523 | 303.089 |
| Operating Income
| 557.917 | 1,091.956 | 843.879 | 509.15 | 384.29 | 413.458 | 473.81 | 378.6 | 167.89 | 63.372 | 119.809 | 226.859 | 158.351 | 79.758 |
| Operating Income Ratio
| 0.112 | 0.194 | 0.177 | 0.133 | 0.098 | 0.102 | 0.119 | 0.099 | 0.048 | 0.018 | 0.037 | 0.061 | 0.041 | 0.025 |
| Total Other Income Expenses Net
| -0.579 | -19.083 | -14.479 | 31.317 | 38.329 | 80.798 | 1.686 | -16.946 | 78.05 | 115.768 | 57.595 | 118.26 | -1.901 | 0.804 |
| Income Before Tax
| 557.338 | 1,072.873 | 829.4 | 502.22 | 376.965 | 494.256 | 475.496 | 361.654 | 245.94 | 171.973 | 177.404 | 286.204 | 182.045 | 93.609 |
| Income Before Tax Ratio
| 0.112 | 0.191 | 0.174 | 0.132 | 0.096 | 0.122 | 0.119 | 0.095 | 0.07 | 0.049 | 0.055 | 0.077 | 0.047 | 0.03 |
| Income Tax Expense
| 137.346 | 223.292 | 156.69 | 102.747 | 52.49 | 96.524 | 89.021 | 75.456 | 42.728 | 27.36 | 46.388 | 49.049 | 6.285 | 0.409 |
| Net Income
| 444.458 | 849.365 | 673.643 | 399.473 | 324.475 | 397.732 | 386.475 | 286.198 | 203.212 | 144.613 | 131.016 | 237.155 | 175.76 | 93.2 |
| Net Income Ratio
| 0.089 | 0.151 | 0.141 | 0.105 | 0.082 | 0.098 | 0.097 | 0.075 | 0.058 | 0.042 | 0.041 | 0.064 | 0.045 | 0.03 |
| EPS
| 4.41 | 8.43 | 6.69 | 4.36 | 3.49 | 4.28 | 4.16 | 3.1 | 2.22 | 1.59 | 1.58 | 3.7 | 2.15 | 1.34 |
| EPS Diluted
| 4.41 | 8.42 | 6.68 | 4.36 | 3.48 | 4.27 | 4.15 | 3.07 | 2.2 | 1.57 | 1.54 | 3.6 | 2.15 | 1.34 |
| EBITDA
| 951.154 | 1,403.779 | 1,127.952 | 765.875 | 622.518 | 613.281 | 666.931 | 549.148 | 407.399 | 245.386 | 293.46 | 537.928 | 339.867 | 230.287 |
| EBITDA Ratio
| 0.191 | 0.25 | 0.236 | 0.202 | 0.166 | 0.173 | 0.169 | 0.138 | 0.122 | 0.105 | 0.111 | 0.118 | 0.097 | 0.078 |